Tallac Therapeutics Funding: $62M Raised, Series A (2020)

Tallac Therapeutics is based in Burlingame. It has raised $62M in total funding. Latest round: Series A.

Tallac Therapeutics funding overview

Tallac Therapeutics is based in Burlingame. Tallac Therapeutics has raised $62M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2020. The round record for Tallac Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, MRL Ventures Fund. 5 distinct backers are named across the disclosed rounds.

Tallac Therapeutics at a glance

Total raised
$62M
Latest round
Series A
Latest round date
December 2020
Headquarters
Burlingame
Notable investors
venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, MRL Ventures Fund

Frequently asked about Tallac Therapeutics funding

How much has Tallac Therapeutics raised?
Tallac Therapeutics has raised $62M in total disclosed funding across the rounds on record.
Who has invested in Tallac Therapeutics?
venBio Partners, Morningside Venture, Lightstone Ventures, Matrix Partners China, MRL Ventures Fund are named among the investors backing Tallac Therapeutics.
What was the latest Tallac Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2020.
Where is Tallac Therapeutics based?
Tallac Therapeutics is based in Burlingame.
When did Tallac Therapeutics last raise?
The last disclosed Tallac Therapeutics round closed in December 2020 at Series A.

Totals shown for Tallac Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Burlingame and the investors behind them below.

Companies related to Tallac Therapeutics (28)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026